Now live: Pro — the full 13F research suite for serious investorsSee pricing →
AIGH Capital Management LLC

Q4 2024 · 13F-HR

AIGH Capital Management LLCholdings as filed

Filed 2025-02-12 · accession 0001214659-25-002461

$319.8M
Reported value
38
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
219350105GLWCORNING INC$32.1M10.0%675,000CALLSOLE
573874104MRVLMARVELL TECHNOLOGY INC$22.1M6.91%200,000CALLSOLE
71535D106PSNLPERSONALIS INC$22.0M6.87%3,799,064CommonSOLE
62857J201MYOMYOMO INC$21.8M6.81%3,381,567CommonSOLE
00770C101ARQARQ INC$21.3M6.67%2,817,078CommonSOLE
24661P807DCTHDELCATH SYS INC$16.7M5.22%1,385,389CommonSOLE
573874104MRVLMARVELL TECHNOLOGY INC$16.6M5.18%150,000CommonSOLE
810648105SCPHSCPHARMACEUTICALS INC$14.8M4.62%4,174,367CommonSOLE
92337C203VSTMVERASTEM INC$13.8M4.31%2,665,043CommonSOLE
532257805LPTHLIGHTPATH TECHNOLOGIES INC$13.1M4.11%3,723,932CommonSOLE
87650L103TARSTARSUS PHARMACEUTICALS INC$12.4M3.89%224,713CommonSOLE
05479K106ELUTELUTIA INC$11.5M3.60%3,074,675CommonSOLE
05637B105BLZEBACKBLAZE INC$10.8M3.39%1,800,000CommonSOLE
09075X108BIODESIX INC$9.5M2.96%6,179,812CommonSOLE
05587G203BKTIBK TECHNOLOGIES CORPORATION$9.2M2.88%268,180CommonSOLE
98422E103XERSXERIS BIOPHARMA HOLDINGS INC$8.7M2.73%2,574,846CommonSOLE
872381108TELATELA BIO INC$8.0M2.51%2,662,785CommonSOLE
22407B108COYACOYA THERAPEUTICS INC$6.9M2.15%1,201,152CommonSOLE
488445206ZVRAZEVRA THERAPEUTICS INC$6.6M2.06%788,614CommonSOLE
28617B606ELVAELECTROVAYA INC$6.3M1.96%2,525,099CommonSOLE
451622203IPWRIDEAL PWR INC$6.2M1.94%823,315CommonSOLE
88338H704TQ80THERATECHNOLOGIES INC$5.5M1.71%3,026,569CommonSOLE
45817G201IDNINTELLICHECK INC$4.5M1.42%1,617,696CommonSOLE
219350105GLWCORNING INC$3.6M1.11%75,000CommonSOLE
M8001Q126PYPDPOLYPID LTD$2.5M0.78%827,867CommonSOLE
00439U104GRCEGRACE THERAPEUTICS INC$2.0M0.61%521,083CommonSOLE
355184102FKWLFRANKLIN WIRELESS CORP$1.9M0.60%390,000CommonSOLE
03836J201APREAPREA THERAPEUTICS INC$1.8M0.55%539,300CommonSOLE
45674E109INABEURIN8BIO INC$1.6M0.50%6,191,865CommonSOLE
45773H409INOINOVIO PHARMACEUTICALS INC$1.2M0.37%654,115CommonSOLE
09077D209BFRIBIOFRONTERA INC$884,0960.28%811,097CommonSOLE
49721T507KPRXKIORA PHARMACEUTICALS INC$850,0820.27%255,555CommonSOLE
483119202KALAEURKALA BIO INC$841,8360.26%121,302CommonSOLE
72941H509CYTXEURPLUS THERAPEUTICS INC$645,0410.20%560,905CommonSOLE
09090D301BIOMX INC$631,8290.20%865,400CommonSOLE
83193D203SMTKSMARTKEM INC$456,2330.14%156,487CommonSOLE
08862L103BEYOND AIR INC$355,4440.11%991,476CommonSOLE
56624R108MCHXMARCHEX INC$346,6750.11%198,100CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.